4[4]Zamanou A,Tsirogianni A,Terzoglou C,et al.Antismooth muscle antibodies (ASMAs) and anti-cytoskeleton antibodies (ACTAs) in liver diseases:a comparison of classical indirect immunofluorescence with ELISA[J].J Clin Lab Anal,2002,16(4):194-201.
5[5]Muratori P,Muratori L,Agostinelli D,et al.Smooth muscle antibodies and type 1 autoimmune hepatitis[J].Autoimmunity,2002,35 (8):497-500.
6[6]Treichel U,McFarlane BM,Seki T,et al.Demographics of anti-asialoglycoprotein receptor autoantibodies in autoimmune hepatitis[J].Gastroenterology,1994,107(3):799-804.
7[7]Strassburg CP,Manns MP.Autoantibodies and autoantigens in autoimmune hepatitis[J].Semin Liver Dis,2002,22(4):339-352.
8[8]Roozendaal C,de Jong MA,van den Berg AP,et al.Clinical significance of anti-neutrophil cytoplasmic antibodies (ANCA) in autoimmune liver diseases[J].J Hepatol,2000,32(5):734-741.
9[9]Strassburg CP,Jaeckel E,Manns MP.Anti-mitochondrial antibodies and other immunological tests in primary biliary cirrhosis[J].Eur J Gastroenterol Hepatol,1999,11(6):595-601.
10[10]Terjung B,Bogsch F,Klein R,et al.Diagnostic accuracy of atypical p-ANCA in autoimmune hepatitis using ROC-and multivariate regression analysis[J].Eur J Med Res,2004,9(9):439-448.
二级参考文献6
1Yukiko N.Immunoe responses to SS2A 522kDa and 602kDa proteinsand to SS2B 502kDa protein in mothers of infants with neonatal lupuserythematosus[J],2000(05).
2Mutasim DF;Adams BB.A practical guide for serologic evaluation of autoimmune connective tissue diseases[J],2000(02).
3Tan EM;Feltkamp TE;Smonlen JS.Range of antinuclear antibodies in"healthy"individuals[J],1997(09).
4Abuaf N;Prost AC;Rouquette-Gally AM.Comparison of human tumor cells (Hep-2) and rat liver for the detection of antinuclear antibodies by indirect immunofluores-cence,1984(05).
